Merck Beats Estimates on Drug and Life Sciences Strength

On this episode of Stock Movers:
- Burberry shares gain 4.8% after the UK trench coat maker reported retail comparable sales for its second quarter that beat analyst estimates, turning positive for the first time in two years
- Merck shares rise 8.6% after third quarter results beat estimates.
- Siemens expects currency headwinds to “strongly” burden growth in revenue as well as profit during the 2026 fiscal year while the manufacturer also deals with costs related to recent acquisitions. The shares declined as much as 3.6% in Frankfurt

See omnystudio.com/listener for privacy information.